From a clinical perspective, since AIB1 can regulate SNAI1/E-cadherin expression, which is an important factor in tumor invasiveness, AIB1 could therefore be considered as potential marker for detecting the malignancy likelihood of breast tumor. Here, NCOA3 is linked to neoplasm.